DAPAGLIFLOZIN
NDC 66993-457, DAPAGLIFLOZIN, tablet, film coated, from Prasco Laboratories.
- Product NDC
- 66993-457
- Status
- Listed
- Labeler
- Prasco Laboratories
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA202293
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/66993-457 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPAGLIFLOZIN PROPANEDIOL10 mg/1
Pharmacologic classes
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 66993-457-30 | 66993045730 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (66993-457-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3aba33aa-f8c6-4b10-85c8-dfa14578d07cNADAC price for package 66993045730
GET /v1/drugs/nadac/66993045730
Use it
Look up 66993-457 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/66993-457 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 66993-457. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.